These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15106800)

  • 1. A common polymorphism of uncoupling protein 2 gene is associated with hypertension.
    Ji Q; Ikegami H; Fujisawa T; Kawabata Y; Ono M; Nishino M; Ohishi M; Katsuya T; Rakugi H; Ogihara T
    J Hypertens; 2004 Jan; 22(1):97-102. PubMed ID: 15106800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncoupling protein-2 polymorphisms in type 2 diabetes, obesity, and insulin secretion.
    Wang H; Chu WS; Lu T; Hasstedt SJ; Kern PA; Elbein SC
    Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E1-7. PubMed ID: 12915397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association study of the -866G/A UCP2 gene promoter polymorphism with type 2 diabetes and obesity in a Tehran population: a case control study.
    Heidari J; Akrami SM; Heshmat R; Amiri P; Fakhrzadeh H; Pajouhi M
    Arch Iran Med; 2010 Sep; 13(5):384-90. PubMed ID: 20804304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncoupling protein 2 promoter polymorphism -866G/A affects its expression in beta-cells and modulates clinical profiles of Japanese type 2 diabetic patients.
    Sasahara M; Nishi M; Kawashima H; Ueda K; Sakagashira S; Furuta H; Matsumoto E; Hanabusa T; Sasaki H; Nanjo K
    Diabetes; 2004 Feb; 53(2):482-5. PubMed ID: 14747301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncoupling protein 2 promoter polymorphism -866G/A affects peripheral nerve dysfunction in Japanese type 2 diabetic patients.
    Yamasaki H; Sasaki H; Ogawa K; Shono T; Tamura S; Doi A; Sasahara M; Kawashima H; Nakao T; Furuta H; Nishi M; Nanjo K
    Diabetes Care; 2006 Apr; 29(4):888-94. PubMed ID: 16567833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular screening of uncoupling protein 2 gene in patients with noninsulin-dependent diabetes mellitus or obesity.
    Kubota T; Mori H; Tamori Y; Okazawa H; Fukuda T; Miki M; Ito C; Fleury C; Bouillaud F; Kasuga M
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2800-4. PubMed ID: 9709950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The -866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes.
    D'Adamo M; Perego L; Cardellini M; Marini MA; Frontoni S; Andreozzi F; Sciacqua A; Lauro D; Sbraccia P; Federici M; Paganelli M; Pontiroli AE; Lauro R; Perticone F; Folli F; Sesti G
    Diabetes; 2004 Jul; 53(7):1905-10. PubMed ID: 15220218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of candidate genes in Polish families with obesity.
    Malczewska-Malec M; Wybranska I; Leszczynska-Golabek I; Partyka L; Hartwich J; Jabrocka A; Kiec-Wilk B; Kwasniak M; Motyka M; Dembinska-Kiec A
    Clin Chem Lab Med; 2004 May; 42(5):487-93. PubMed ID: 15202783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Common variants in beta 3-adrenergic-receptor and uncoupling protein-2 genes are associated with type 2 diabetes and obesity].
    Xiu LL; Weng JP; Sui Y; Wang J; Yan JH; Huang ZM
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):375-9. PubMed ID: 15061987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The frequent UCP2 -866G>A polymorphism protects against insulin resistance and is associated with obesity: a study of obesity and related metabolic traits among 17 636 Danes.
    Andersen G; Dalgaard LT; Justesen JM; Anthonsen S; Nielsen T; Thørner LW; Witte D; Jørgensen T; Clausen JO; Lauritzen T; Holmkvist J; Hansen T; Pedersen O
    Int J Obes (Lond); 2013 Feb; 37(2):175-81. PubMed ID: 22349573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of the coding region of the uncoupling protein 2 gene in obese NIDDM patients: impact of a common amino acid polymorphism on juvenile and maturity onset forms of obesity and insulin resistance.
    Urhammer SA; Dalgaard LT; Sørensen TI; Møller AM; Andersen T; Tybjaerg-Hansen A; Hansen T; Clausen JO; Vestergaard H; Pedersen O
    Diabetologia; 1997 Oct; 40(10):1227-30. PubMed ID: 9349606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the E23K polymorphism in the KCNJ11 gene with gestational diabetes mellitus.
    Shaat N; Ekelund M; Lernmark A; Ivarsson S; Almgren P; Berntorp K; Groop L
    Diabetologia; 2005 Dec; 48(12):2544-51. PubMed ID: 16320083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple and rapid detection of uncoupling protein-2 - 866G/A polymorphism by mutagenically separated polymerase chain reaction.
    Zhang B; Tanaka H; Saku K
    Clin Chim Acta; 2004 Jun; 344(1-2):205-10. PubMed ID: 15149891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of a common polymorphism in the promoter of UCP2 with susceptibility to multiple sclerosis.
    Vogler S; Goedde R; Miterski B; Gold R; Kroner A; Koczan D; Zettl UK; Rieckmann P; Epplen JT; Ibrahim SM
    J Mol Med (Berl); 2005 Oct; 83(10):806-11. PubMed ID: 16021520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An association study of abdominal obesity and polymorphisms of UCP2 and SREBP1c genes].
    Song Y; Li N; He L; Chen Q; Tang X; Chen DF; Wang JW; Dou HD; Liu HD; Hu YH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Jun; 41(3):302-6. PubMed ID: 19727213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The common -866G/A polymorphism of the UCP2 gene in healthy Iranians compared with world populations.
    Akrami SM; Heidari J; Heshmat R; Amiri P; Fakhrzadeh H; Pajouhi M
    Hum Biol; 2007 Feb; 79(1):103-10. PubMed ID: 17985659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The UCP2 -866 G>A promoter region polymorphism is associated with nonalcoholic steatohepatitis.
    Fares R; Petta S; Lombardi R; Grimaudo S; Dongiovanni P; Pipitone R; Rametta R; Fracanzani AL; Mozzi E; Craxì A; Fargion S; Sesti G; Valenti L
    Liver Int; 2015 May; 35(5):1574-80. PubMed ID: 25351290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A functional polymorphism in the promoter of UCP2 enhances obesity risk but reduces type 2 diabetes risk in obese middle-aged humans.
    Krempler F; Esterbauer H; Weitgasser R; Ebenbichler C; Patsch JR; Miller K; Xie M; Linnemayr V; Oberkofler H; Patsch W
    Diabetes; 2002 Nov; 51(11):3331-5. PubMed ID: 12401727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation in UCP2 (uncoupling protein-2) is associated with energy metabolism in Pima Indians.
    Kovacs P; Ma L; Hanson RL; Franks P; Stumvoll M; Bogardus C; Baier LJ
    Diabetologia; 2005 Nov; 48(11):2292-5. PubMed ID: 16167150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No evidence for involvement of the promoter polymorphism -866 G/A of the UCP2 gene in childhood-onset obesity in humans.
    Schäuble N; Geller F; Siegfried W; Goldschmidt H; Remschmidt H; Hinney A; Hebebrand J
    Exp Clin Endocrinol Diabetes; 2003 Apr; 111(2):73-6. PubMed ID: 12746756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.